CorbinThera

Entreprise en démarrage développant inhibiteurs d’USP15 neutoprotecteurs - Startup company developing neuroprotective USP15 inhibitors / Dr Philippe Gros McGill

[Apellis Pharma @ApellisPharma]

10 yrs. ago, Apellis was founded on the vision of creating a biotech known for its compassion, revolutionary science, and 
contributions to humankind. 10 yrs. later, we honor those who got us to this point and those that will help us achieve this vision over the next 10 yrs.

[Immune Biosolutions @iBiosolutions]

The coolest hotspot, livre from Bio-Japan! @iBiosolutions @BIO_Qc @PhenoSwitch @Sema_Thera

[Maxime Ranger @max_ranger]

MyX presents new data at PODD conference https://t.co/375fQxO8l1

[AmorChem @AmorChem]

Greg White, CEO of @AmorChem portfolio company MyX Therapeutics, spreading the word on veterinary applications for our mucoadhesive nanoparticles, at the @fetchdvm360 conference in #KansasCity today!
[Pic courtesy of the Canadian Consulate]

[Kim Furlong (she/her) @kim_furlong]

Thank you ⁦@amberkanwar⁩ and ⁦@BNNBloomberg⁩ for the opportunity to discuss the results of the ⁦@CVCACanada⁩ H1 results and current investments trends! https://t.co/pbHBm9pQRc

[Maxime Ranger @max_ranger]

Job posting | AmorChem | Toronto, Ontario
https://t.co/Sf3blhrcRj

[Sylvain Carle @sylvain]

Il y a au moins quatre postes de direction (incubation, accélération et investissement) ouverts dans mon réseau présentement. Dans de très bonnes organisations. Si vous êtes curieux/curieuse, faites-moi signe...

[UoD Life Sciences @UoDLifeSciences]

.@DDU_Dundee has licensed assets to Corbin Therapeutics to develop possible new treatments for neuroinflammation-based disorders, including multiple sclerosis (MS) https://t.co/yW1Swb5Khg @corbin_thera

[J-F Pariseau @JFPariseau]

I’m just sayin’.... #AmpVC #WeGoto11 #BiotechRocks

[Maxime Ranger @max_ranger]

@VBougie Bravo Vero! Your contribution for this application was key! Congrats

[UAlberta Research @UofAResearch]

Congrats to @GlycoNet & #UAlberta Christopher Cairo & @UMontreal ’s Alexey Pshezhetsky; winners of coveted @AmorChem's KNOCK OUT prize to advance #CardiovascularDisease & #AutoimmuneDisease research. @Cairo_Lab

[Maxime Ranger @max_ranger]

Bravo à Martin Leblanc et Caprion. Les nouvelles du jour - La Presse+ https://t.co/1AyaskNuPI

[CQDM @CQDM_Canada]

CQDM, @HBHLMcGill, @corbin_thera and @BrainCanada sont fiers d'annoncer le financement d'1,5M$ au Dr. Philippe Gros pour la mise au point de molécules destinées à combattre la neuroinflammation #biopharma

Plus d'informations : https://t.co/5yWTVP5QJv

[AmorChem @AmorChem]

We gave @max_ranger the w/end off, to think about his vision for a 2020 version of #SweetPharnaDay - he earned that - but knowing him, he will arrive on Monday morning bursting with ideas! By the way, many congrats to TATUM on making history as the first ever SPD winners!

[AmorChem @AmorChem]

There can only be one winner but we feel that all three contenders in our KNOCK OUT 2019 competition are winners! Drs. Pshezhetsky/Cairo, Drs. Moroy/Moitessier and Dr. Tremblay all put up valiant efforts in the face of tough jabs from our judges panel. Bravo to one and all!

[EFFERVESCENCE MTL @EffervescenceV]

Roberto Bellini, Président et CEO de @BELLUSHealth anime un panel sur les leviers de financements privés et publics aux côtés de @SarahM_Jenna, MIMS, François Ravenelle, @inversago, Étienne Lagacé, @moonshothealth et Sean MacDonald, @corbin_thera.

[AmorChem @AmorChem]

500,000 congratulations to our KNOCK OUT 2019 winners - Drs. Alexey Pshezhetsky and Christopher Cairo - who rolled with the punches and came back swinging for the victory this year. Bravo!

[AmorChem @AmorChem]

Third and final contestants confidently enter the fray - Drs. Tarik Moroy and Nicolas Moitessier - despite Christopher Hall confusing their target with the origins of a certain @amorchem partner! 🇮🇪

[Immune Biosolutions @iBiosolutions]

Super Panel on private-public financing of biotech! #effervescencemtl @inversago @SarahM_Jenna @corbin_thera @BELLUSHealth